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specific question. Furthermore, three illustrative cases from 
clinical practice are described.
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Introduction
Osteomyelitis covers a wide range of bone infections caused 
by an infecting organism. Normally, bone is resistant to 
bacterial colonization; in trauma however the bone integ-
rity can be disrupted by fractures, surgery or the presence 
of metal implants which makes it more vulnerable to exog-
enous microbial invasion. This, combined with the typically 
acute setting in which trauma surgery takes place with pos-
sibly contaminated open fractures and concomitant soft tis-
sue injuries leads to a reported incidence of 1 to 19 % of 
deep infections after surgical fracture care. Not only this 
high infection rate is a concern but also due to an increase 
in surgical procedures over the last decades, fracture related 
osteomyelitis, also referred to as posttraumatic osteomyeli-
tis (PTO), becomes more and more an entity that trauma—
and orthopaedic surgeons will have to deal with [1, 2].
Essential for a successful treatment of PTO is an early 
recognition of the possible infection and therefore a prompt 
and accurate diagnostic strategy. A surgical site infection 
(SSI) occurs in the early phase (first 2 weeks after surgery) 
and can usually be recognized by clinical examination, since 
mostly the well-known four signs of an infection (swelling, 
redness, pain and heat) are present. In the later phases of 
PTO these signs may not be present and diagnosis can be 
difficult. It is however of invaluable importance to diagnose 
PTO as early as possible and to start early and specific treat-
ment, since a late recognition or inadequate treatment may 
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result in prolonged disease duration, high recurrence rate, 
high morbidity and sometimes even an amputation [3].
The diagnostic problem in PTO is that there is no single 
routine test available that can detect an infection with suffi-
ciently high diagnostic accuracy. Mostly, a combination of 
clinical, laboratory, microbiological and medical imaging 
tests is performed [4] and the followed strategy depends on 
personal experience, tradition, financial aspects of the insti-
tute and best available evidence.
Diagnostic imaging routinely performed consists of plain 
X-rays and computed tomography (CT). These techniques are 
helpful to assess the position of metal implants and the union 
rate of the fracture, but are not able to differentiate between 
infection and inflammation. Magnetic resonance imag-
ing (MRI) is better able to recognize infections; however, 
the metal implants can introduce artefacts and its diagnos-
tic accuracy decreases after recent surgery as differentiation 
between sterile inflammation and infected tissue is difficult 
[5–7]. To our opinion, nuclear medicine imaging techniques 
play an important role in the diagnostic pathway to diagnose 
PTO. Nuclear medicine, which focusses at the pathophysi-
ology of processes, is a booming area within the medicinal 
community. Pathophysiological changes usually precede ana-
tomical changes, often leading to an earlier and possibly more 
accurate diagnosis. Recent developments in hybrid camera 
systems, combining the best of both anatomy and physiology 
with higher spatial resolution and better quantification possi-
bilities, provides new opportunities and possibilities for these 
hybrid imaging modalities to play an important role in both 
diagnosis and therapy evaluation in patients with PTO.
The aim of this paper is to explain the existing nuclear 
medicine imaging possibilities for diagnosing PTO, how 
these modalities are able to answer the diagnostic questions 
from the clinicians (trauma and orthopaedic surgeons) and 
to provide an overview of which nuclear imaging technique 
should be used at which time point of the diagnostic 
pathway.
Nuclear medicine in general; SPECT and PET
In nuclear medicine, radiopharmaceuticals (a radioactive ele-
ment attached to a chemical compound or pharmaceutical 
specific for a disease process) are administered intravenously 
into the patient. As a result, images are performed from radia-
tion which is emitted at the location of the disease/infectious 
process from within the patient. This characteristic forms the 
main distinction with radiology, which mainly focuses on tis-
sue anatomy by using external radiation sources.
The two main camera systems used in nuclear medicine 
to visualize the radiopharmaceuticals are the gamma cam-
era and the PET camera (Fig. 1). These camera systems 
detect the γ-rays emitted from the patient and transform it 
into an image (planar and/or 3D).
The already since the 1970s existing gamma camera 
forms the basis of conventional nuclear medicine by provid-
ing 2D planar imaging of the body. However, this technique 
has several limitations: image quality is rather poor and the 
spatial resolution of the gamma camera is limited to approxi-
mately 8 mm. Furthermore, it is difficult, based on 2D images 
with overlapping structures, to determine exactly where the 
increased uptake is located. The effect of this superposition can 
be overcome by collecting images from different angles (64 
or 128) around the patient, thereby creating a 3D image. This 
technique, called single photon emission computed tomography 
(SPECT), leads to a higher contrast and improves sensitivity.
Positron emission tomography (PET) is a more recently 
(1990s) developed unique imaging tool to visualize various 
pathophysiological processes in the body. This technique 
is based on radionuclides that emit positrons (positively 
Fig. 1  Left image gamma camera with SPECT-CT possibility (Siemens Symbia T). Right PET-CT camera (Siemens Biograph mCT 64-slice). 
Image courtesy: Siemens Medical Systems, Knoxville, TN
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charged electrons) to become stable. Emitting positrons 
cannot exist freely, and therefore it meets his antimatter 
and annihilates into two γ-ray photons, each with the same 
energy and moving in opposite directions. The PET camera 
exist of a ring-shaped detector system which can detect the 
two photons when arriving within a certain time frame at 
opposite detectors. Recent developments in software lead 
to a correction method for the time a photon needs to travel 
from its origin to the detector. This software development, 
called time-of-flight (TOF) has major advantages for spa-
tial resolution.
The major advantage of PET above SPECT is that that 
PET camera system has a greater efficacy in detecting pho-
tons, and a better spatial resolution of around 3–4 mm. Fur-
thermore, quantification possibilities are better with PET.
Added value of hybrid imaging; SPECT/CT 
and PET/CT
As already mentioned, recent development in both soft- 
and hardware led to the implementation of hybrid systems, 
combining SPECT and PET with CT. Both the nuclear 
medicine and radiological technique are performed in an 
immediate sequential setting, without changing the position 
of the patients, leading to an almost perfect correlation of 
pathophysiological with anatomical information. Further-
more, costs are reduced (one imaging modality), and the 
one-stop-shop principle (one combined scan instead of two 
separate scans at two different departments) reduces wait-
ing time for the patient.
Very recently, PET systems were also combined with 
MRI, thereby introducing the PET/MRI hybrid imaging 
system. In these PET/MRI systems, the different modali-
ties can be used in a simultaneous setting. PET/MRI has 
several major theoretical advantages that could be of inter-
est for the whole medical community [8]. At the moment, 
this modality is mainly used in neurology and cardiology 
and its role in infectious processes in the musculoskeletal 
system has to be established.
Nuclear medicine techniques to image PTO
Many radiopharmaceuticals are available to image infec-
tious and inflammatory processes [9]. Only the world-
wide most commonly used nuclear medicine techniques to 
image PTO will be discussed here by explaining the tech-
nical details of the procedure supplemented with a brief 
overview of the relevant literature. Finally, we will provide 
some illustrative clinical examples.
Bone scintigraphy
Technique
Bone scintigraphy is one of the oldest existing nuclear 
medicine techniques and still one of the cornerstones in 
nuclear medicine practice. Radiopharmaceuticals used for 
bone scintigraphy are diphosphonates coupled to the radi-
onuclide Technetium-99 m (99mTc). These bone-seeking 
radiopharmaceuticals selectively accumulate on the surface 
on bone mineral matrix in areas of high metabolic activity 
and therefore depict osteoblastic activity.
When a musculoskeletal infection is suspected, a three 
phase bone scintigraphy can be performed as a first screen-
ing tool (Fig. 2). As revealed by its name, this bone scin-
tigraphy consists of three phases. The first phase is the per-
fusion phase, or flow study, performed dynamically, over 
the part of interest, for the first 2 min after administration 
of the radiopharmaceutical. The second phase is the blood 
pool phase, also performed on the part of interest, directly 
after the first phase (2–5 min after injection). The third 
phase, also called the static phase, depicts the incorpora-
tion of the radiopharmaceutical into the matrix of the bone 
and is usually performed 3 h after administration. This late 
phase can be combined with a SPECT-CT to localize the 
area(s) of increased bone metabolism. All three phases are 
necessary in case of suspected bone infection, since the 
three phases characterize both the vascularization and the 
metabolic activity of a process.
Bone scintigraphy in PTO
The three-phase bone scan can be used as a first screening 
method for diagnosing PTO. Because of its good avail-
ability it can mostly be performed short (<24 h) after the 
request of the referring clinician and it is relatively cheap. 
A normal bone scan (no increased perfusion and blood pool, 
no uptake in the late phase) rules out almost completely an 
existing bone infection (high sensitivity). The role of the 
bone scintigraphy, however, in the acute setting is neglecta-
ble, since the specificity is rather low and uptake is visible 
in all sites of increased bone metabolism irrespective of the 
underlying cause. A positive bone scan with an increased 
vascularity and increased metabolic uptake may indicate 
PTO; yet it can also indicate healing fracture(s) or a post-
surgical situation. Furthermore, in a low-grade infection 
even the first two phases can be negative, so the late phase 
is essential and when positive it may be the only indication 
of an infection. Literature studies trying to find out at which 
time point a bone scan becomes negative after fractures 
and/or surgery are scarce. It is known that a bone scan may 
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be positive for at least 2 years after total hip arthroplasty 
(THA) and 5 years after total knee arthroplasty (TKA) due 
to physiological bone remodeling after implantation [5]. We 
do not know exactly the time frame in which the bone scan 
is definitely positive following trauma, fracture or after open 
reduction and internal fixation (ORIF) of a fracture. Prob-
ably this time period will be around 1–2 years.
In conclusion, there is no role for a bone scintigraphy 
for diagnosing a SSI or early PTO. There is probably a role 
(when negative it excludes an infection) in the long-stand-
ing PTO, but a positive bone scintigraphy must be inter-
preted with caution and other imaging methods are neces-
sary to differentiate between an infection and other causes 
of increased osteoblastic activity.
The “better” bone scan
The conventional bone scan as mentioned above is still the 
gold standard in bone imaging. The images are acquired on 
a gamma camera and most newer camera systems have also 
the possibility to include SPECT-CT in the imaging pro-
cess. However, there is also a PET tracer for bone imaging 
which uses the radiopharmaceutical 18F-sodium fluoride 
(18F-NaF). The uptake mechanism of 18F-NaF resembles 
that of 99mTc-labelled diphosphonates. The faster blood 
clearance and the twofold higher uptake in developing bone 
cells of fluoride make it possible to image faster (1 h after 
injection) and lead to better ratios between pathological and 
physiological bone uptake [10]. The advantages of using 
Fig. 2  Example of a normal three-phase bone scan in a patient with 
pain complaints of the lumbar spine. Upper row images: flow/per-
fusion images (phase 1). Lower row, left image blood pool image 
(phase 2). Lower row, middle image (anterior view, phase 3), right 
image (posterior view, phase 3)
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this PET tracer is the better resolution and better quantifica-
tion possibilities. Limitations, however, are the higher costs 
and the lower availability worldwide of this techniques, and 
the non-possibility to perform flow and blood pool imag-
ing. At this moment, the classical bone scan with labelled 
diphosphonates remains the gold standard when a bone 
scan is indicated; the 18F-NaF-PET could be considered for 
the individual patient.
White blood cell (WBC) scintigraphy
Technique
Scintigraphy using labelled autologous white blood cells 
(WBC scintigraphy or leukocyte scintigraphy) was devel-
oped in the 1970s and is still the gold standard nuclear 
medicine technique for infections in the musculoskeletal 
system. It is a specific indicator for leukocyte infiltration 
into infected bone and soft tissue and is highly specific, 
since the WBCs accumulate by active migration to the 
infection. Over time, there have been major developments 
regarding how to correctly acquire, analyze and interpret 
the images, which eventually led to a high diagnostic accu-
racy. Also the possibility to better anatomically localize the 
infection due to the addition of SPECT-CT helped reach 
these good results mentioned in the literature.
Despite the high diagnostic accuracy, the whole proce-
dure itself has limitations. First of all, 50–100 cc of blood 
has to be collected from the patient. Then, the prepara-
tion of the labelled (preferably with 99mTc-HMPAO) white 
blood cells is laborious and time consuming (2–3 h) and 
must be performed under sterile conditions and strict 
regulations [11]. Subsequently, the labeled autologous 
leukocytes are reinjected into the patient. Finally, at least 
two imaging time points are necessary: 3–4 h after rein-
jection and 20–24 h after reinjection. This dual-time point 
imaging has to be performed since the accumulation of 
leukocytes in the infection is a dynamic process: it is the 
increase in size or intensity in time that indicates the pres-
ence of an infection (Fig. 3). When there is a decrease or 
the uptake is stable in time, then there is no infection but 
inflammation or physiological bone marrow uptake [8]. 
This change in uptake in time can be determined visually, 
but sometimes semi-quantitative evaluation can be a help-
ful tool as an addition to visual assessment. This is done 
by calculating ratios between the infectious focus and the 
contralateral side as background. Again, increase of the 
ratio in time points to an infection. Due to disintegration 
of the used radionuclide (99mTc), the total acquisition time 
of the late images has to be prolonged accordingly to the 
half-life of the tracer to establish identical image quality. 
In accordance with the bone scintigraphy, a SPECT/CT can 
be performed to exactly localize the leukocyte uptake. The 
proposed correct procedure of acquisition and analysis of 
the scans are stated in a recent publication [12].
White blood cell scintigraphy in PTO
The role of WBC scintigraphy in peripheral osteomyelitis 
is extensively studied. Prandini et al. described in a meta-
analysis of published papers up to December 2005, in 
almost 3600 cases, a diagnostic accuracy of 89 % [13]. In 
the included studies, however, different acquisition pro-
tocols and interpretation criteria were used. Furthermore, 
Fig. 3  Example of a positive 
WBC scintigraphy of a 39 years 
old patient with osteomyelitis 
of the right tibia. Left image 
anterior view 4 h after injec-
tion. Right image anterior view 
24 h after injection. Increase in 
uptake in time, especially when 
the background uptake is taking 
into account: suspect for an 
infection
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SPECT-CT did not exist at that time. So, probably the 
diagnostic accuracy is even higher when using the correct 
and standardized protocols and add the complementary 
information obtained by SPECT-CT. This was confirmed 
in two recent retrospective studies using these correct pro-
tocols in, respectively, 61 and 31 patients with peripheral 
osteomyelitis. The diagnostic accuracy in these studies 
was found to be very high: 97 and 100 %, respectively 
[12, 14].
The difficulty with interpreting the literature on the 
accuracy of WBC scintigraphy for diagnosing PTO is that 
most of these studies included patients with peripheral 
skeletal infections in general (including haematogenous 
osteomyelitis and prosthetic joint infections). Recently, 
we performed a systematic review of the recent literature 
(2000–2015) on the role of imaging modalities in patients 
with PTO (data not published yet). Only studies were 
included in which data for at least 10 patients with PTO 
were available, and a valid reference test (proven by histol-
ogy or bacteriology, and/or clinical follow-up of more than 
6 months) was described. Unfortunately, only 10 studies 
could be included of which 5 were performed with WBC 
scintigraphy (only one study reported a diagnostic accu-
racy, which was 98 %). So, despite the extensively available 
data of WBC scintigraphy in peripheral osteomyelitis in 
general, there is a lack of studies really focusing on PTO. 
Despite this disappointing finding, we believe that there is 
an absolute role for WBC scintigraphy in diagnosing PTO. 
This is based on expert opinion and best available evidence 
on osteomyelitis in general since it is the only existing 
imaging modality that is a specific indicator of an infection. 
Therefore, we retrospectively reviewed the diagnostic value 
of WBC scintigraphy ± SPECT/CT in 114 patients with 
suspected PTO in our hospital. Sensitivity, specificity, posi-
tive predictive value and negative predictive value were 89, 
95, 86 and 97 %, respectively (data to be published).
18F‑Fluorodeoxyglucose (FDG)‑PET
Technique
The glucose analogue FDG is already extensively used in 
oncology for over a decade. It can also be used in infec-
tious diseases, because activated leukocytes, monocytes, 
lymphocytes, macrophages and giant cells all use glu-
cose as their energy source. To minimize FDG uptake 
in normal tissue, patients must fast for at least 4–6 h to 
reduce competition for glucose transporters on the cell 
Fig. 4  Patient with a proven 
tuberculosis osteomyelitis of 
the left shoulder. FDG-PET 
was performed to identify any 
disseminated foci of infection. 
FDG-PET image (left) and 
fusion PET-CT image (right) 
showing multiple infectious foci 
in the body (left shoulder, multi-
ple vertebras, right upper arm, 
left upper leg)
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membrane. After the injection of the labelled FDG (18F-
FDG) patients must rest for an hour and limit physical 
activity to minimize muscle uptake and obtain a good 
biodistribution in the body. High contrast images of 
infectious lesions can be obtained with this technique. 
The use of FDG-PET has many advantages: no blood 
manipulation, high spatial resolution, one imaging time 
point which is already 60 min after injection, one-stop-
shop possibility with diagnostic CT, etc. It is therefore an 
essential tool when searching for an infection or inflam-
mation in a patient with fever of unknown origin or to 
establish the source of dissemination of infectious lesions 
in the body in a patient with an haematogeneous spread of 
the infection (Fig. 4).
Unfortunately, the uptake in both inflammatory and 
infectious cells makes this technique also very aspecific 
as it is often not possible to discriminate between inflam-
mation and infection. No universal accepted interpretation 
criteria are available to declare a FDG-PET scan positive or 
negative for an infection, let alone for PTO. Furthermore, 
uptake of FDG in the peripheral skeleton results in a rather 
broad differential diagnosis. Osteomyelitis, soft tissue 
infection, inflammation, granulation tissue after surgery, 
reactive uptake around foreign body material, atherosclero-
sis, recent fractures and neuro-osteoarthropathy all lead to 
increased FDG uptake.
FDG‑PET in PTO
As is the case with WBC scintigraphy, most data are avail-
able for FDG-PET imaging in long-standing (chronic) 
peripheral osteomyelitis. Termaat et al. performed a sys-
tematic review and meta-analysis for the assessment of 
chronic osteomyelitis and found the best results for FDG-
PET with a sensitivity of 96 % and a specificity of 91 % 
[15]. Similar results were found by Jamar et al., who pooled 
all available data (in total 287 cases) and found a diagnos-
tic accuracy of 94.5 % [16]. However, most of these stud-
ies dealt with chronic osteomyelitis from a diverse etiology 
and the exact role of FDG-PET in the posttraumatic situ-
ation is not known. Theoretically, due to reactive inflam-
mation, the performance may be worse with osteosynthesis 
in situ, as is the case in prosthetic joint infections.
In the same systematic review our group performed as 
mentioned earlier, only 6 FDG-PET studies (with or with-
out combined CT scan) were identified that were published 
in the last 15 years and fulfilled the criteria of >10 patients 
with suspected PTO and a valid reference test. The reported 
diagnostic accuracies were between 67 and 91 % (data not 
published yet).
In 2013, a shared guideline for the use of FDG in inflam-
mation and infection was published by both the European 
Association of Nuclear Medicine (EANM) and the Society 
of Nuclear Medicine and Molecular Imaging (SNMMI) in 
the United States. This guideline states that the evidence for 
the use of FDG in osteomyelitis remains low (2b at best), 
and that at this moment, WBC scintigraphy is the preferred 
imaging modality. If FDG-PET is used however it is best 
performed in the chronic peripheral non postoperative set-
ting [16].
Questions from surgeon’s
In daily clinical practice in patients with suspected PTO, 
the trauma and orthopaedic surgeons have in general the 
following questions for the medical imaging specialists:
Is the involved bone viable and are there sequestra?
To answer this question, a three-phase bone scintigraphy 
(preferably combined with a SPECT/CT) is required to see 
if there is perfusion and osteoblastic activity of the involved 
bone. In the case of suspected PTO, this is the only inquiry 
that is to be answered by bone scintigraphy. However, as 
said before: image quality is rather poor and the spatial res-
olution of the gamma camera is limited to approximately 
8 mm, smaller sequestra can therefore be missed. When 
there is uptake, in the setting of PTO, it is often increased 
in intensity due to recent fracture or surgery, healing oste-
oblastic activity or osteomyelitis. Other imaging methods 
are then necessary to differentiate between these possibili-
ties for the increased uptake.
Is there an infection?
In patients with suspected PTO, with recent fracture and/
or surgery, and osteosynthesis materials in situ, WBC scin-
tigraphy is required. Increased uptake, increasing in size or 
intensity in time, indicate the presence of an infection.
In the late phase, and we do not know exactly the time 
point after fracture, probably 1–2 years, and without oste-
osynthesis in situ, FDG-PET is the best option, since this 
modality is easier to perform, has a high spatial resolution 
and only one imaging acquisition is necessary.
When there is an infection, where is it located: in the 
bone or in the soft tissues?
This question is easy to answer with the now existing 
hybrid camera systems. When available, always perform 
SPECT-CT when there is uptake visible at the WBC scin-
tigraphy and always perform PET-CT when the FDG-PET 
modality is used. With the anatomical correlation it is easy 
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to localize exactly the area of increased accumulation: in 
(osteomyelitis) or outside (soft tissue infection) the bone.
When should we use which nuclear technique?
In our opinion, these are the preferred nuclear imaging 
techniques for answering the different questions in a patient 
with suspected PTO (partly adapted from [17]:
Non‑union, is there vital bone: Three phase bone scan with SPECT-CT
Non‑union, is there an infection: WBC scintigraphy with SPECT-CT
Suspected peripheral PTO, no surgery or surgery >6 months ago and no 
osteosynthesis materials in situ: FDG-PET/CT
Suspected peripheral PTO, osteosynthesis materials in situ, placement <2 
years ago: WBC scintigraphy with SPECT-CT
Suspected peripheral PTO, osteosynthesis in situ, placement >2 years 
ago: Three phase bone scan, followed by WBC scintigraphy with 
SPECT-CT if the bone scan is positive
Suspected PTO located in the axial skeleton: FDG-PET/CT
Suspected dissemination of infectious foci: FDG-PET/CT
Examples from clinical practice
Patient A
Clinical story
Patient A, a 37-year-old healthy male, underwent open 
reduction and internal fixation (ORIF) of an open fracture 
of his right distal tibia and fibula 22 years ago. This was 
complicated by posttraumatic osteomyelitis and resulted 
in multiple re-operations with debridements of the bone, 
removal of most hardware and free flap coverage of a soft 
tissue defect. He was referred to our hospital with a per-
sistent clinical infection around his right distal tibia and a 
near wound breakdown of the scar. Medical imaging was 
requested (a) to confirm the diagnosis of osteomyelitis and 
(b) to determine the anatomical location of the suspected 
osteomyelitis.
Fig. 5  WBC scan (a–d images after 4 h, e–f images after 24 h) and late phase bone scan (g anterior view, h lateral view) of patient A
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Imaging results
First, according to the diagnostic imaging protocol in our 
hospital, a three-phase bone scan was performed since the 
fracture and surgery were >2 years ago. All three phases 
of the bone scan were positive, only the late phase (Fig. 5, 
g: anterior view, h: lateral view) is presented here. This 
increased osteoblastic uptake can be the result of an infec-
tion, but also due to a healing fracture or recent surgery. 
For further differentiation, the patient underwent a WBC 
Fig. 6  WBC scan SPECT-CT 
of patient A
Fig. 7  X-ray (left image) and bone scan (upper row flow phase, middle image lower row blood pool phase, right image lower row SPECT-CT 
late phase) of patient B
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scan (Fig. 5, a–d: images after 4 h, e–f: images after 
24 h). This showed increased uptake in both intensity and 
size over time, suspect for an infection. To localize this 
accumulation of leukocytes a SPECT-CT was performed 
(Fig. 6) which revealed that the uptake was located out-




Patient B, a 46-year-old schizophrenic but otherwise 
healthy male sustained an open and comminuted talar neck 
fracture after a fall from height. This was initially treated 
Fig. 8  WBC scan (upper row images after 4 h, lower row images after 24 h) of patient B
Fig. 9  WBC scan (left image anterior view after 4 h, right image: anterior view after 24 h) of patient C
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with multiple soft tissue debridements and an external fixa-
tion, later augmented with screw and K-wire fixation of 
the fracture. The soft tissue defect was closed with a local 
myocutaneous flap. Two months after this last procedure, 
the patient presented with a draining sinus in the scar on 
the lateral side of the ankle joint. Medical imaging was 
requested to (a) assess the viability of the talus and (b) to 
determine the anatomic location of the suspected osteomy-
elitis. The X-ray is shown in Fig. 7 (left image).
Imaging results
To answer question (a) a three phase bone scan was per-
formed. The first phase (flow phase) is shown in Fig. 7 
(upper row images): positive flow at the talar region of 
the left foot. Obviously also the second phase (blood 
pool phase, middle image lower row) and the late phase 
(combined with CT image, right image lower row) are pos-
itive. This means the bone is viable. However, differentia-
tion between infection or healing fracture is not possible. 
Therefore, WBC scintigraphy was performed (Fig. 8, upper 
row: images after 4 h, lower row: images after 24 h). The 
uptake decreased in time, meaning that the leukocyte accu-
mulation is the result of a healing fracture and not of an 




Patient C, a 33-year-old healthy male was referred to 
our hospital because of a suspected posttraumatic osteo-
myelitis in combination with a malunion of his left tibia. 
Fig. 10  WBC SPECT-CT of patient C
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He sustained a gunshot wound to his left lower leg in 
the middle east conflict 2 years prior to this presentation 
which was treated with a prolonged immobilization in an 
external fixator combined with several wound debride-
ments. The last operation was only a few months prior 
to presentation. On examination, apart from the obvious 
malalignment of his left lower leg, we noted a closed but 
unstable scar on the medial side of his left tibia. Medical 
imaging was requested to (a) confirm the diagnosis and 
(b) to determine the anatomic location of the suspected 
osteomyelitis.
Imaging results
Since his last surgery was <6 months ago, immedi-
ately a WBC scan was performed (Fig. 9, left image: 
anterior view after 4 h, right image: anterior view after 
24 h): uptake is visible at three locations. When cal-
culating the ratios (uptake focus-to-contralateral side) 
the uptake at the most proximal and most distal focus 
decreases in time. This means these uptakes are due 
to regeneration of bone marrow. However, the uptake 
at the middle focus increases in time, which is sus-
pect for an infection. The SPECT-CT (Fig. 10) shows 
the uptake in the bone and a small fistula to the bone 
marrow. Indeed, surgery revealed an infection at this 
location.
Conclusion
Nuclear medicine modalities play an important role in the 
assessment of posttraumatic osteomyelitis. Three phase 
bone scintigraphy can be used to exclude PTO in long-
standing cases, but when positive other imaging techniques 
are necessary. WBC scintigraphy, when using the correct 
acquisition, analysis and interpretation protocols, is a spe-
cific technique to diagnose an infection with high diagnos-
tic accuracy. FDG-PET has several advantages and can per-
fectly be used in a chronic non postoperative setting, but 
should be interpreted with caution when metal implants are 
in situ or when surgery was performed recently. The pros 
and cons of the three different techniques are summarized 
in Table 1.
Prospective studies comparing these nuclear medicine 
imaging techniques with radiological imaging techniques 
like MRI are necessary to provide evidence based diagnos-
tic flowcharts in patients with suspected PTO.
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